Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata. This update typically reflects non-critical text or metadata changes without altering core study information.
    Difference
    0.0%
    Check dated 2026-07-04T03:49:25.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, signaling a minor update to the page rendering and metadata. The study content and data remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T01:26:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    New sections such as How to Read a Study Record, Common Questions, and How to Join a Study appear, improving guidance and navigation on the study page. The recruitment status note No longer looking for participants indicates that enrollment has closed, aligning the page with the study's current status.
    Difference
    0.1%
    Check dated 2026-06-12T15:42:15.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new minor update to the page documentation or metadata. No study content or user-facing information appears to be changed.
    Difference
    0.0%
    Check dated 2026-06-05T10:55:47.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    A new citation about surgical outcomes from KEYNOTE-522 was added to the Publications section, and the 'Online ahead of print' note was removed from that citation.
    Difference
    0.0%
    Check dated 2026-05-29T09:19:31.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Updated the Italy site listing by changing Macerata, Italy, 62100 to Province of Macerata, Italy, 62100, adding a more precise regional designation to the trial site. The change also introduces a new version tag, Revision: v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-15T04:48:59.000Z thumbnail image

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.